Gabriel Chodick

15.1k total citations · 5 hit papers
378 papers, 8.2k citations indexed

About

Gabriel Chodick is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gabriel Chodick has authored 378 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 63 papers in Surgery and 50 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gabriel Chodick's work include SARS-CoV-2 and COVID-19 Research (23 papers), Diabetes Treatment and Management (21 papers) and COVID-19 Clinical Research Studies (19 papers). Gabriel Chodick is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Diabetes Treatment and Management (21 papers) and COVID-19 Clinical Research Studies (19 papers). Gabriel Chodick collaborates with scholars based in Israel, United States and United Kingdom. Gabriel Chodick's co-authors include Varda Shalev, Anthony Heymann, Ehud Kokia, Inbal Goldshtein, Sivan Gazit, Amir Ben‐Tov, Tal Patalon, Rachel Katz, Roy Kishony and Idan Yelin and has published in prestigious journals such as Science, JAMA and Journal of Clinical Investigation.

In The Last Decade

Gabriel Chodick

358 papers receiving 8.0k citations

Hit Papers

Initial report of decreas... 2019 2026 2021 2023 2021 2019 2022 2021 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
    2021 305 citations Idan Yelin, Rachel Katz et al. profile →
  2. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study
    2019 223 citations Gabriel Chodick et al. profile →
  3. Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections
    2022 205 citations Mathew Stracy, Olga Snitser et al. Science profile →
  4. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women
    2021 191 citations Inbal Goldshtein, Ran S. Rotem et al. profile →
  5. Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy
    2023 68 citations Ran S. Rotem, Gabriel Chodick et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gabriel Chodick 1.5k 1.2k 1.2k 896 751 378 8.2k
François Alla 1.5k 1.0× 2.2k 1.8× 1.4k 1.2× 694 0.8× 579 0.8× 241 8.8k
Adrían V. Hernández 1.4k 0.9× 2.1k 1.8× 2.5k 2.1× 607 0.7× 1.2k 1.6× 320 13.3k
Laurence S. Magder 1.1k 0.7× 3.0k 2.5× 995 0.9× 356 0.4× 682 0.9× 291 13.9k
Arnon Afek 607 0.4× 1.2k 1.0× 1.0k 0.9× 698 0.8× 1.3k 1.8× 235 8.3k
Jennifer L. St. Sauver 934 0.6× 4.4k 3.6× 1.7k 1.4× 1.4k 1.5× 713 0.9× 298 14.4k
Anders Hviid 1.5k 1.0× 2.4k 2.0× 1.0k 0.9× 265 0.3× 692 0.9× 159 6.8k
Carlos King Ho Wong 1.6k 1.0× 982 0.8× 1.3k 1.1× 1.4k 1.6× 370 0.5× 348 6.5k
Lamberto Manzoli 942 0.6× 1.3k 1.1× 790 0.7× 272 0.3× 388 0.5× 257 8.6k
Alex Brown 535 0.3× 1.4k 1.1× 646 0.6× 614 0.7× 412 0.5× 397 8.4k
Elizabeth Loder 490 0.3× 1.6k 1.3× 1.9k 1.6× 613 0.7× 872 1.2× 171 14.6k

Countries citing papers authored by Gabriel Chodick

Since Specialization
Citations

This map shows the geographic impact of Gabriel Chodick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Chodick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Chodick more than expected).

Fields of papers citing papers by Gabriel Chodick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Chodick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Chodick. The network helps show where Gabriel Chodick may publish in the future.

Co-authorship network of co-authors of Gabriel Chodick

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Chodick. A scholar is included among the top collaborators of Gabriel Chodick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Chodick. Gabriel Chodick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davidovits, Miriam, et al.. (2025). Eculizumab is efficacious and safe in pediatric patients with various forms of hemolytic uremic syndrome: a retrospective clinical experience of a tertiary center. Frontiers in Pharmacology. 16. 1535407–1535407. 1 indexed citations
2.
Chodick, Gabriel, et al.. (2025). Inflammatory bowel disease is associated with an increased risk of cardiovascular events in a sex and age-dependent manner: A historical cohort study. International Journal of Cardiology Cardiovascular Risk and Prevention. 24. 200363–200363. 1 indexed citations
3.
Schiller, Tal, et al.. (2025). An Oral Glucose Tolerance Test in Pregnancy Can Serve as a Valuable Predictor for Future Diabetes. The Journal of Clinical Endocrinology & Metabolism. 111(3). e669–e679. 1 indexed citations
4.
Weil, Clara, Lilac Tene, Gabriel Chodick, et al.. (2024). Outcomes and Healthcare Resource Utilization in Patients with COVID-19 Treated with Nirmatrelvir–Ritonavir: Real-World Data Analysis. Journal of Clinical Medicine. 13(20). 6091–6091.
5.
Dreyfuss, Michael, Benjamin Lebwohl, Sivan Gazit, et al.. (2024). A machine learning tool for early identification of celiac disease autoimmunity. Scientific Reports. 14(1). 30760–30760. 1 indexed citations
6.
7.
8.
Chodick, Gabriel, Ran S. Rotem, Todd A. Miano, Warren B. Bilker, & Sean Hennessy. (2024). Adherence with statins and all‐cause mortality in days with high temperature. Pharmacoepidemiology and Drug Safety. 33(6). e5817–e5817. 1 indexed citations
9.
Chodick, Gabriel, et al.. (2024). Epidemiology and Healthcare Service Utilization among Adults with Chronic Cough. Journal of Clinical Medicine. 13(11). 3230–3230. 2 indexed citations
10.
Barer, Yael, et al.. (2023). Progressive supranuclear palsy’s economical burden: the use and costs of healthcare resources in a large health provider in Israel. Journal of Neurology. 270(8). 3770–3778. 1 indexed citations
11.
Nevo, Yoram, Huda Mussaffi, Gabriel Chodick, et al.. (2023). Evaluation of sputum cultures in children with spinal Muscular atrophy. Respiratory Medicine. 209. 107143–107143. 3 indexed citations
12.
Levinsky, Yoel, et al.. (2023). Adherence to colchicine prophylaxis among patients with familial Mediterranean fever treated with interleukin-1 inhibitors. Seminars in Arthritis and Rheumatism. 61. 152211–152211. 2 indexed citations
13.
Siegelmann‐Danieli, Nava, Victoria Neiman, Avital Bareket‐Samish, et al.. (2023). Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate. 84(1). 39–46. 2 indexed citations
14.
Ozery-Flato, Michal, et al.. (2023). Impact of the COVID-19 Pandemic on Clinical Findings in Medical Imaging Exams in a Nationwide Israeli Health Organization: Observational Study. JMIR Formative Research. 7. e42930–e42930. 1 indexed citations
15.
16.
Stracy, Mathew, Olga Snitser, Idan Yelin, et al.. (2022). Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections. Science. 375(6583). 889–894. 205 indexed citations breakdown →
17.
18.
Amarilyo, Gil, Gabriel Chodick, Gideon Koren, et al.. (2018). Poor long-term adherence to secondary penicillin prophylaxis in children with history of rheumatic fever. Seminars in Arthritis and Rheumatism. 48(6). 1019–1024. 7 indexed citations
19.
Yu, Jingbo, Inbal Goldshtein, Sofia Ish‐Shalom, et al.. (2016). Cost and Consequences of Nonadherence With Oral Bisphosphonate Therapy. Annals of Pharmacotherapy. 50(4). 262–269. 17 indexed citations
20.
Weitzman, Dahlia, Gabriel Chodick, Varda Shalev, Chagai Grossman, & Ehud Grossman. (2014). Prevalence and Factors Associated With Resistant Hypertension in a Large Health Maintenance Organization in Israel. Hypertension. 64(3). 501–507. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Alla Breakdown of academic impact, for papers by Adrían V. Hernández Breakdown of academic impact, for papers by Laurence S. Magder Breakdown of academic impact, for papers by Arnon Afek Breakdown of academic impact, for papers by Jennifer L. St. Sauver Breakdown of academic impact, for papers by Anders Hviid Breakdown of academic impact, for papers by Carlos King Ho Wong Breakdown of academic impact, for papers by Lamberto Manzoli Breakdown of academic impact, for papers by Alex Brown Breakdown of academic impact, for papers by Elizabeth Loder
Rankless by CCL
2026